Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations
- PMID: 19549989
- DOI: 10.1182/blood-2009-03-213504
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations
Abstract
The glycoprotein VI (GPVI)/FcRgamma complex is a key receptor for platelet activation by collagen. We describe, for the first time, 2 genetic abnormalities in one patient. This 10-year-old girl presented ecchymoses since infancy, a prolonged bleeding time despite a normal platelet count and no antiplatelet antibodies. Collagen-induced platelet activation was null, whereas GPVI quantification by flow cytometry evidenced an incomplete deficiency. Immunoblotting showed an abnormal migration of residual GPVI, and no FcRgamma defect. GPVI DNA sequencing revealed (1) an R38C mutation in exon 3 of one allele and (2) an insertion of 5 nucleotides in exon 4 of the other allele, leading to a premature nonsense codon and absence of the corresponding mRNA. Introduction of the R38C mutation into recombinant GPVI-Fc resulted in abnormal protein migration and a loss of collagen binding. Thus, this composite genetic GPVI deficiency and dysfunction cause absence of platelet responses to collagen and a mild bleeding phenotype.
Similar articles
-
An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families.J Thromb Haemost. 2013 Sep;11(9):1751-9. doi: 10.1111/jth.12334. J Thromb Haemost. 2013. PMID: 23815599
-
Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface.Blood. 2004 Sep 1;104(5):1350-5. doi: 10.1182/blood-2004-03-0896. Epub 2004 May 18. Blood. 2004. PMID: 15150079
-
A familial platelet function disorder associated with abnormal signalling through the glycoprotein VI pathway.Br J Haematol. 2007 Jun;137(6):569-77. doi: 10.1111/j.1365-2141.2007.06603.x. Br J Haematol. 2007. PMID: 17539777
-
Platelet glycoprotein VI.Adv Exp Med Biol. 2008;640:53-63. doi: 10.1007/978-0-387-09789-3_5. Adv Exp Med Biol. 2008. PMID: 19065783 Review.
-
Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI.Blood Rev. 2019 Nov;38:100592. doi: 10.1016/j.blre.2019.100592. Epub 2019 Jul 22. Blood Rev. 2019. PMID: 31351674 Review.
Cited by
-
Restraining of glycoprotein VI- and integrin α2β1-dependent thrombus formation by platelet PECAM1.Cell Mol Life Sci. 2024 Jan 18;81(1):44. doi: 10.1007/s00018-023-05058-2. Cell Mol Life Sci. 2024. PMID: 38236412 Free PMC article.
-
Strengths and Weaknesses of Light Transmission Aggregometry in Diagnosing Hereditary Platelet Function Disorders.J Clin Med. 2020 Mar 12;9(3):763. doi: 10.3390/jcm9030763. J Clin Med. 2020. PMID: 32178287 Free PMC article. Review.
-
Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis.Int J Mol Sci. 2021 Sep 14;22(18):9915. doi: 10.3390/ijms22189915. Int J Mol Sci. 2021. PMID: 34576080 Free PMC article.
-
Targeting GPVI as a novel antithrombotic strategy.J Blood Med. 2014 May 21;5:59-68. doi: 10.2147/JBM.S39220. eCollection 2014. J Blood Med. 2014. PMID: 24899824 Free PMC article. Review.
-
Improving treatment for acute ischemic stroke-Clot busting innovation in the pipeline.Front Med Technol. 2022 Aug 1;4:946367. doi: 10.3389/fmedt.2022.946367. eCollection 2022. Front Med Technol. 2022. PMID: 35978568 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases